Doreen LePage

1.2k total citations
24 papers, 888 citations indexed

About

Doreen LePage is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Doreen LePage has authored 24 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Doreen LePage's work include Synthesis and Biological Activity (4 papers), Cell Adhesion Molecules Research (3 papers) and Synthesis and Biological Evaluation (2 papers). Doreen LePage is often cited by papers focused on Synthesis and Biological Activity (4 papers), Cell Adhesion Molecules Research (3 papers) and Synthesis and Biological Evaluation (2 papers). Doreen LePage collaborates with scholars based in United States, Spain and Italy. Doreen LePage's co-authors include Arthur E. Bogdén, William R. Cobb, Henry J. Esber, R. Blake Pepinsky, Alan Gill, Abhijit Chakraborty, Paul Rayhorn, E. Whalley, Darren P. Baker and Paula S. Hochman and has published in prestigious journals such as Journal of Clinical Investigation, Cancer and Cancer Research.

In The Last Decade

Doreen LePage

24 papers receiving 847 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Doreen LePage United States	11	450	291	163	131	101	24	888
IR Hart United Kingdom	14	594 1.3×	317 1.1×	134 0.8×	67 0.5×	151 1.5×	18	976
Brian C.‐S. Liu United States	20	635 1.4×	194 0.7×	127 0.8×	125 1.0×	72 0.7×	44	1.3k
Karen Morrison United Kingdom	14	299 0.7×	233 0.8×	177 1.1×	78 0.6×	67 0.7×	23	826
Erich Weber Switzerland	10	418 0.9×	396 1.4×	174 1.1×	48 0.4×	85 0.8×	17	757
Jörg Ringel Germany	11	541 1.2×	670 2.3×	223 1.4×	74 0.6×	52 0.5×	23	1.1k
Shiro Kataoka Japan	13	480 1.1×	219 0.8×	183 1.1×	78 0.6×	52 0.5×	27	717
Vanessa Baeriswyl Switzerland	12	728 1.6×	452 1.6×	150 0.9×	158 1.2×	78 0.8×	14	1.1k
Kanji Hojo Japan	11	560 1.2×	242 0.8×	91 0.6×	48 0.4×	105 1.0×	21	974
Cristina Basilico Italy	17	669 1.5×	352 1.2×	126 0.8×	56 0.4×	48 0.5×	31	1.3k
Jay Overholser United States	11	439 1.0×	358 1.2×	186 1.1×	138 1.1×	48 0.5×	16	767

Countries citing papers authored by Doreen LePage

Since Specialization

Citations

This map shows the geographic impact of Doreen LePage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doreen LePage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doreen LePage more than expected).

Fields of papers citing papers by Doreen LePage

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doreen LePage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doreen LePage. The network helps show where Doreen LePage may publish in the future.

Co-authorship network of co-authors of Doreen LePage

This figure shows the co-authorship network connecting the top 25 collaborators of Doreen LePage. A scholar is included among the top collaborators of Doreen LePage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doreen LePage. Doreen LePage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Guillén, María José, Doreen LePage, Wendy Grant, Carmen Cuevas, & Pablo Avilés. (2009). Abstract #2018: Antitumor activity of PM00104 in hepatocellular carcinoma (HCC) experimental models. 69. 2018–2018. 4 indexed citations

2.

Caers, Jo, Eline Menu, Hendrik De Raeve, et al.. (2008). Antitumour and antiangiogenic effects of Aplidin® in the 5TMM syngeneic models of multiple myeloma. British Journal of Cancer. 98(12). 1966–1974. 33 indexed citations

3.

LePage, Doreen, Halina Sasak, María José Guillén, et al.. (2007). Antitumor activity of Zalypsis® (PM00104) in experimental models of bladder, gastric and liver cancer.. Molecular Cancer Therapeutics. 6. 5 indexed citations

4.

Muñoz, María José, Enrique Álvarez, Teresa Martı́nez, et al.. (2007). JNK activation as an in vivo marker of Aplidin® activity.. Cancer Research. 67. 5580–5580. 4 indexed citations

5.

Maier, Armin, et al.. (2007). Evaluation of antitumor efficacy of Plitidepsin in vitro in 72 patient derived tumor xenografts using a clonogenic assay and determination of a predictive gene signature. 6. 1 indexed citations

6.

Greiner, Thomas U., Armin Maier, Heinz H. Fiebig, et al.. (2007). Preclinical evaluation of PM00104 to support the selection of tumor indications for clinical development. 6. 3 indexed citations

7.

Sasak, Halina, Doreen LePage, Carmen Cuevas, et al.. (2007). Antitumor activity of Aplidin® in combination with Velcade® (bortezomib) in human multiple myeloma.. 67. 4762–4762. 1 indexed citations

8.

Elices, Mariano J., Doreen LePage, Wendy Grant, et al.. (2006). Activity of pm02734 against human breast and prostate tumors. Cancer Research. 66. 1107–1107. 3 indexed citations

9.

LePage, Doreen, Douglas Lazarus, Mariano J. Elices, et al.. (2006). Aplidin® combination with chemotherapeutic agents in human melanoma tumors. 66. 504–504. 1 indexed citations

10.

Pepinsky, R. Blake, Mark Cornebise, Alan Gill, et al.. (2005). Design, Synthesis, and Analysis of a Polyethelene Glycol-Modified (PEGylated) Small Molecule Inhibitor of Integrin α4β1 with Improved Pharmaceutical Properties. Journal of Pharmacology and Experimental Therapeutics. 312(2). 742–750. 17 indexed citations

11.

Adkins, Heather B., Caterina Bianco, Susan G. Schiffer, et al.. (2003). Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo. Journal of Clinical Investigation. 112(4). 575–587. 134 indexed citations

12.

Leone, Diane R., Keith Giza, Alan Gill, et al.. (2003). An Assessment of the Mechanistic Differences Between Two Integrin α4β1 Inhibitors, the Monoclonal Antibody TA-2 and the Small Molecule BIO5192, in Rat Experimental Autoimmune Encephalomyelitis. Journal of Pharmacology and Experimental Therapeutics. 305(3). 1150–1162. 48 indexed citations

13.

Adkins, Heather B., Caterina Bianco, Susan G. Schiffer, et al.. (2003). Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo. Journal of Clinical Investigation. 112(4). 575–587. 6 indexed citations

14.

Pepinsky, R. Blake, Reneé Shapiro, Shaoshan Wang, et al.. (2002). Long‐acting forms of Sonic hedgehog with improved pharmacokinetic and pharmacodynamic properties are efficacious in a nerve injury model. Journal of Pharmaceutical Sciences. 91(2). 371–387. 56 indexed citations

15.

LePage, Doreen, et al.. (1996). Proliferative response of human prostate tumour xenografts to surgical trauma and the transurethral resection of the prostate controversy. British Journal of Cancer. 73(1). 73–78. 7 indexed citations

16.

Bogdén, Arthur E., William R. Cobb, & Doreen LePage. (1988). The 6-day subrenal capsule assay (SRCA): its criticism, biology and review of assay/clinical correlations.. PubMed. 276. 139–204. 1 indexed citations

17.

Griffin, Thomas W., Carol Richardson, L. L. Houston, et al.. (1987). Antitumor activity of intraperitoneal immunotoxins in a nude mouse model of human malignant mesothelioma.. PubMed. 47(16). 4266–70. 58 indexed citations

18.

Bogdén, Arthur E., et al.. (1981). Chemotherapy responsiveness of human tumors as first transplant generation xenografts in the normal mouse: Six-day subrenal capsule assay. Cancer. 48(1). 10–20. 106 indexed citations

19.

Bogdén, Arthur E., et al.. (1980). Surgical explants of human tumors as first transplant generation xenografts for new drug screening in vivo. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 283. 2 indexed citations

20.

Bogdén, Arthur E., et al.. (1979). Growth of Human Tumor Xenografts Implanted under the Renal Capsule of Normal Immunocompetent Mice. Pathobiology. 47(4). 281–293. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact